Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GTGAACGCCCACCAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTT| |TGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAA
End
7713686/7573555 (Hg38)
Nearest miRNA
hsa-mir-7158/Upstream/923116; hsa-mir-10b/Downstream/2619059;
Upstream sequence
ATAAGAAAAGCTTAGCATAGTTTTCTGTGCTCCAATTAAAAAGAAGAATCTTTTAGAAGAGCTTTCACAAGCTGGATAGCAGCTTCCTCCAATCTGGAAT
Downstream sequence
TGAAGTATGAGTCTCACTTTCACACGTATCCTCAGGCAACAGCATCATTCCCACAACATAAAGACGAATGTAAGACTCTACTGTGTGGGACACACTGCGG
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.